Gapping up
In reaction to earnings/guidance:
- FTCH +14.3%, WDAY +11.5%, GPS +6.2%, ULTA +3.6%, JKS +3.3%
Other news:
- MFGP +94.6% (OTEX to acquire MFGP)
- ETNB +7.4% (results from Entrigue phase 2 trial of pegozafermin)
- BBBY +2.7% (confirms it will hold strategic update call on Aug 31)
- ALSN +2.1% (wins $6.55 mln US Army contract for electrified transmissions for armored combat vehicles)
- XRAY +2% (names new CEO)
- APLD +1.6% (expects to have three data centers operating by 1H23 also reports earnings)
- BCRX +1.4% (Presents Data Demonstrating >99 Percent Suppression of Alternative Pathway Complement Activity with BCX9930 in C3G Patients)
- PRG +0.9% (responds to PA attyy general decision to file a complaint)
Analyst comments:
- VTEX +4.9% (upgraded to Buy from Neutral at BofA Securities)
- FSLR +2.3% (upgraded to Buy from Neutral at BofA Securities)
- HIBB +2.1% (upgraded to Buy from Neutral at Seaport Research Partners)
- FDS +0.4% (upgraded to Buy from Hold at Deutsche Bank)